A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A109.5 KBALPINE IMMUNE SCIENCES, INC.Nov 14, 4:45 PM ET·0001172661-24-005283
- SC 13D/A81.4 KBALPINE IMMUNE SCIENCES, INC.May 21, 4:49 PM ET·0001104659-24-063883
- SC 13D/A177.2 KBALPINE IMMUNE SCIENCES, INC.May 21, 10:21 AM ET·0001193125-24-143527
- 8-K361.4 KBALPINE IMMUNE SCIENCES, INC.May 20, 8:38 AM ET·0001193125-24-142285
- 10-Q5.2 MBALPINE IMMUNE SCIENCES, INC.May 9, 4:22 PM ET·0001626199-24-000064
- 8-K247.3 KBALPINE IMMUNE SCIENCES, INC.May 9, 4:09 PM ET·0001626199-24-000063
- SC 13D/A111.0 KBALPINE IMMUNE SCIENCES, INC.Apr 30, 4:20 PM ET·0001104659-24-054965
- SC 13D/A244.0 KBALPINE IMMUNE SCIENCES, INC.Apr 29, 6:08 PM ET·0001193125-24-123019
- 10-K/A816.9 KBALPINE IMMUNE SCIENCES, INC.Apr 25, 7:48 PM ET·0001626199-24-000059
- 8-K931.6 KBALPINE IMMUNE SCIENCES, INC.Apr 10, 4:26 PM ET·0001193125-24-091936
Insiders
10- Alpine ImmunoSciences, L.P.10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
- BVF INC/IL10% Owner
- BVF PARTNERS L P/IL10% Owner
- BVF Partners OS Ltd.See Explanation of Responses
- Carruthers R MichaelExec VP/CFO
- Congleton JonDirector, President and CEO
- CONWAY ROBERT EDirector
- Cui XiangminDirector, 10% Owner
Tickers
No tickers on record
Addresses
business
188 EAST BLAINE ST., SUITE 200
SEATTLE, WA, 98102
mailing
188 EAST BLAINE ST., SUITE 200
SEATTLE, WA, 98102
Former Names
- Nivalis Therapeutics, Inc.2017-07-25
- N30 Pharmaceuticals, Inc.2014-11-25